aluates Reports

$ 0.0

Automative

Global Chemical Drug CDMO Market Research Report 2024

Published Date: November 2024

Report Code: QYRE-Auto-22E18357

BUY CHAPTERS

Global Chemical Drug CDMO Market Research Report 2024

Code: QYRE-Auto-22E18357

Report

November 2024

Pages:140

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Catalent

Thermo Fisher Scientific

Lonza

Siegfried

Recipharm

Boehringer Ingelheim

WuXi AppTech

Wuxi Biologics

Fareva

Samsung Biologics

Aenova

Delpharm

Strides Pharma

Piramal

Famar

Curia

Jubilant

Vetter

AGC Pharma Chemicals

Asymchem

Pharmaron

Eurofins

Ascendia Pharmaceuticals

Ardena

CPL

UPM Pharmaceuticals

FUJIFILM Diosynth Biotechnologies

Groupe Parima

TBD Pharmatech

Avid Bioservices

NextPharma

Alcami

Societal CDMO

MedPharm Ltd.

EUROAPI

BioVectra

Pfizer CentreOne

Fermion

Chemical Drug CDMO Market Size

The global Chemical Drug CDMO market was valued at US$ 85810 million in 2023 and is anticipated to reach US$ 139990 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.

Chemical Drug CDMO Market

Chemical drug CDMO services play a vital role in accelerating the drug development timeline by offering expertise in formulation, process development, and large-scale manufacturing. These organizations handle everything from lab-scale development to commercial production, allowing pharmaceutical companies to focus on innovation and market strategies. By partnering with CDMOs, companies can access advanced technologies and flexible production capabilities, which are essential for efficiently navigating regulatory requirements and launching chemical drugs to the market in a timely manner.

North American market for Chemical Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Chemical Drug CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Chemical Drug CDMO in Large Enterprise is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Chemical Drug CDMO include Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, Boehringer Ingelheim, WuXi AppTech, WuXi Biologics, Fareva, Samsung Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Chemical Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemical Drug CDMO.

The Chemical Drug CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chemical Drug CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chemical Drug CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chemical Drug CDMO Market Report

Report Metric	Details
Report Name	Chemical Drug CDMO Market
Accounted market size in 2023	US$ 85810 million
Forecasted market size in 2030	US$ 139990 million
CAGR	7.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	API CDMO FDF CDMO Packaging CDMO Other
Segment by Application	Large Enterprise Small and Medium Enterprises Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, Boehringer Ingelheim, WuXi AppTech, WuXi Biologics, Fareva, Samsung Biologics, Aenova, Delpharm, Strides Pharma, Piramal, Famar, Curia, Jubilant, Vetter, AGC Pharma Chemicals, Asymchem, Pharmaron, Eurofins, Ascendia Pharmaceuticals, Ardena, CPL, UPM Pharmaceuticals, FUJIFILM Diosynth Biotechnologies, Groupe Parima, TBD Pharmatech, Avid Bioservices, NextPharma, Alcami, Societal CDMO, MedPharm, Euroapi, BioVectra, Pfizer CentreOne, Fermion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chemical Drug CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Chemical Drug CDMO Market growing?

Ans: The Chemical Drug CDMO Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Chemical Drug CDMO Market size in 2030?

Ans: The Chemical Drug CDMO Market size in 2030 will be US$ 139990 million.

Who are the main players in the Chemical Drug CDMO Market report?

Ans: The main players in the Chemical Drug CDMO Market are Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, Boehringer Ingelheim, WuXi AppTech, WuXi Biologics, Fareva, Samsung Biologics, Aenova, Delpharm, Strides Pharma, Piramal, Famar, Curia, Jubilant, Vetter, AGC Pharma Chemicals, Asymchem, Pharmaron, Eurofins, Ascendia Pharmaceuticals, Ardena, CPL, UPM Pharmaceuticals, FUJIFILM Diosynth Biotechnologies, Groupe Parima, TBD Pharmatech, Avid Bioservices, NextPharma, Alcami, Societal CDMO, MedPharm, Euroapi, BioVectra, Pfizer CentreOne, Fermion

What are the Application segmentation covered in the Chemical Drug CDMO Market report?

Ans: The Applications covered in the Chemical Drug CDMO Market report are Large Enterprise, Small and Medium Enterprises, Other

What are the Type segmentation covered in the Chemical Drug CDMO Market report?

Ans: The Types covered in the Chemical Drug CDMO Market report are API CDMO, FDF CDMO, Packaging CDMO, Other

Recommended Reports

CDMO Services

Drug Development

Biologics & Devices

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chemical Drug CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 API CDMO

1.2.3 FDF CDMO

1.2.4 Packaging CDMO

1.2.5 Other

1.3 Market by Application

1.3.1 Global Chemical Drug CDMO Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Large Enterprise

1.3.3 Small and Medium Enterprises

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chemical Drug CDMO Market Perspective (2019-2030)

2.2 Global Chemical Drug CDMO Growth Trends by Region

2.2.1 Global Chemical Drug CDMO Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Chemical Drug CDMO Historic Market Size by Region (2019-2024)

2.2.3 Chemical Drug CDMO Forecasted Market Size by Region (2025-2030)

2.3 Chemical Drug CDMO Market Dynamics

2.3.1 Chemical Drug CDMO Industry Trends

2.3.2 Chemical Drug CDMO Market Drivers

2.3.3 Chemical Drug CDMO Market Challenges

2.3.4 Chemical Drug CDMO Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chemical Drug CDMO Players by Revenue

3.1.1 Global Top Chemical Drug CDMO Players by Revenue (2019-2024)

3.1.2 Global Chemical Drug CDMO Revenue Market Share by Players (2019-2024)

3.2 Global Chemical Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chemical Drug CDMO Revenue

3.4 Global Chemical Drug CDMO Market Concentration Ratio

3.4.1 Global Chemical Drug CDMO Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chemical Drug CDMO Revenue in 2023

3.5 Global Key Players of Chemical Drug CDMO Head office and Area Served

3.6 Global Key Players of Chemical Drug CDMO, Product and Application

3.7 Global Key Players of Chemical Drug CDMO, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chemical Drug CDMO Breakdown Data by Type

4.1 Global Chemical Drug CDMO Historic Market Size by Type (2019-2024)

4.2 Global Chemical Drug CDMO Forecasted Market Size by Type (2025-2030)

5 Chemical Drug CDMO Breakdown Data by Application

5.1 Global Chemical Drug CDMO Historic Market Size by Application (2019-2024)

5.2 Global Chemical Drug CDMO Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Chemical Drug CDMO Market Size (2019-2030)

6.2 North America Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Chemical Drug CDMO Market Size by Country (2019-2024)

6.4 North America Chemical Drug CDMO Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chemical Drug CDMO Market Size (2019-2030)

7.2 Europe Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Chemical Drug CDMO Market Size by Country (2019-2024)

7.4 Europe Chemical Drug CDMO Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chemical Drug CDMO Market Size (2019-2030)

8.2 Asia-Pacific Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Chemical Drug CDMO Market Size by Region (2019-2024)

8.4 Asia-Pacific Chemical Drug CDMO Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chemical Drug CDMO Market Size (2019-2030)

9.2 Latin America Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Chemical Drug CDMO Market Size by Country (2019-2024)

9.4 Latin America Chemical Drug CDMO Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chemical Drug CDMO Market Size (2019-2030)

10.2 Middle East & Africa Chemical Drug CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Chemical Drug CDMO Market Size by Country (2019-2024)

10.4 Middle East & Africa Chemical Drug CDMO Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Catalent

11.1.1 Catalent Company Details

11.1.2 Catalent Business Overview

11.1.3 Catalent Chemical Drug CDMO Introduction

11.1.4 Catalent Revenue in Chemical Drug CDMO Business (2019-2024)

11.1.5 Catalent Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Details

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Chemical Drug CDMO Introduction

11.2.4 Thermo Fisher Scientific Revenue in Chemical Drug CDMO Business (2019-2024)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Lonza

11.3.1 Lonza Company Details

11.3.2 Lonza Business Overview

11.3.3 Lonza Chemical Drug CDMO Introduction

11.3.4 Lonza Revenue in Chemical Drug CDMO Business (2019-2024)

11.3.5 Lonza Recent Development

11.4 Siegfried

11.4.1 Siegfried Company Details

11.4.2 Siegfried Business Overview

11.4.3 Siegfried Chemical Drug CDMO Introduction

11.4.4 Siegfried Revenue in Chemical Drug CDMO Business (2019-2024)

11.4.5 Siegfried Recent Development

11.5 Recipharm

11.5.1 Recipharm Company Details

11.5.2 Recipharm Business Overview

11.5.3 Recipharm Chemical Drug CDMO Introduction

11.5.4 Recipharm Revenue in Chemical Drug CDMO Business (2019-2024)

11.5.5 Recipharm Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Chemical Drug CDMO Introduction

11.6.4 Boehringer Ingelheim Revenue in Chemical Drug CDMO Business (2019-2024)

11.6.5 Boehringer Ingelheim Recent Development

11.7 WuXi AppTech

11.7.1 WuXi AppTech Company Details

11.7.2 WuXi AppTech Business Overview

11.7.3 WuXi AppTech Chemical Drug CDMO Introduction

11.7.4 WuXi AppTech Revenue in Chemical Drug CDMO Business (2019-2024)

11.7.5 WuXi AppTech Recent Development

11.8 WuXi Biologics

11.8.1 WuXi Biologics Company Details

11.8.2 WuXi Biologics Business Overview

11.8.3 WuXi Biologics Chemical Drug CDMO Introduction

11.8.4 WuXi Biologics Revenue in Chemical Drug CDMO Business (2019-2024)

11.8.5 WuXi Biologics Recent Development

11.9 Fareva

11.9.1 Fareva Company Details

11.9.2 Fareva Business Overview

11.9.3 Fareva Chemical Drug CDMO Introduction

11.9.4 Fareva Revenue in Chemical Drug CDMO Business (2019-2024)

11.9.5 Fareva Recent Development

11.10 Samsung Biologics

11.10.1 Samsung Biologics Company Details

11.10.2 Samsung Biologics Business Overview

11.10.3 Samsung Biologics Chemical Drug CDMO Introduction

11.10.4 Samsung Biologics Revenue in Chemical Drug CDMO Business (2019-2024)

11.10.5 Samsung Biologics Recent Development

11.11 Aenova

11.11.1 Aenova Company Details

11.11.2 Aenova Business Overview

11.11.3 Aenova Chemical Drug CDMO Introduction

11.11.4 Aenova Revenue in Chemical Drug CDMO Business (2019-2024)

11.11.5 Aenova Recent Development

11.12 Delpharm

11.12.1 Delpharm Company Details

11.12.2 Delpharm Business Overview

11.12.3 Delpharm Chemical Drug CDMO Introduction

11.12.4 Delpharm Revenue in Chemical Drug CDMO Business (2019-2024)

11.12.5 Delpharm Recent Development

11.13 Strides Pharma

11.13.1 Strides Pharma Company Details

11.13.2 Strides Pharma Business Overview

11.13.3 Strides Pharma Chemical Drug CDMO Introduction

11.13.4 Strides Pharma Revenue in Chemical Drug CDMO Business (2019-2024)

11.13.5 Strides Pharma Recent Development

11.14 Piramal

11.14.1 Piramal Company Details

11.14.2 Piramal Business Overview

11.14.3 Piramal Chemical Drug CDMO Introduction

11.14.4 Piramal Revenue in Chemical Drug CDMO Business (2019-2024)

11.14.5 Piramal Recent Development

11.15 Famar

11.15.1 Famar Company Details

11.15.2 Famar Business Overview

11.15.3 Famar Chemical Drug CDMO Introduction

11.15.4 Famar Revenue in Chemical Drug CDMO Business (2019-2024)

11.15.5 Famar Recent Development

11.16 Curia

11.16.1 Curia Company Details

11.16.2 Curia Business Overview

11.16.3 Curia Chemical Drug CDMO Introduction

11.16.4 Curia Revenue in Chemical Drug CDMO Business (2019-2024)

11.16.5 Curia Recent Development

11.17 Jubilant

11.17.1 Jubilant Company Details

11.17.2 Jubilant Business Overview

11.17.3 Jubilant Chemical Drug CDMO Introduction

11.17.4 Jubilant Revenue in Chemical Drug CDMO Business (2019-2024)

11.17.5 Jubilant Recent Development

11.18 Vetter

11.18.1 Vetter Company Details

11.18.2 Vetter Business Overview

11.18.3 Vetter Chemical Drug CDMO Introduction

11.18.4 Vetter Revenue in Chemical Drug CDMO Business (2019-2024)

11.18.5 Vetter Recent Development

11.19 AGC Pharma Chemicals

11.19.1 AGC Pharma Chemicals Company Details

11.19.2 AGC Pharma Chemicals Business Overview

11.19.3 AGC Pharma Chemicals Chemical Drug CDMO Introduction

11.19.4 AGC Pharma Chemicals Revenue in Chemical Drug CDMO Business (2019-2024)

11.19.5 AGC Pharma Chemicals Recent Development

11.20 Asymchem

11.20.1 Asymchem Company Details

11.20.2 Asymchem Business Overview

11.20.3 Asymchem Chemical Drug CDMO Introduction

11.20.4 Asymchem Revenue in Chemical Drug CDMO Business (2019-2024)

11.20.5 Asymchem Recent Development

11.21 Pharmaron

11.21.1 Pharmaron Company Details

11.21.2 Pharmaron Business Overview

11.21.3 Pharmaron Chemical Drug CDMO Introduction

11.21.4 Pharmaron Revenue in Chemical Drug CDMO Business (2019-2024)

11.21.5 Pharmaron Recent Development

11.22 Eurofins

11.22.1 Eurofins Company Details

11.22.2 Eurofins Business Overview

11.22.3 Eurofins Chemical Drug CDMO Introduction

11.22.4 Eurofins Revenue in Chemical Drug CDMO Business (2019-2024)

11.22.5 Eurofins Recent Development

11.23 Ascendia Pharmaceuticals

11.23.1 Ascendia Pharmaceuticals Company Details

11.23.2 Ascendia Pharmaceuticals Business Overview

11.23.3 Ascendia Pharmaceuticals Chemical Drug CDMO Introduction

11.23.4 Ascendia Pharmaceuticals Revenue in Chemical Drug CDMO Business (2019-2024)

11.23.5 Ascendia Pharmaceuticals Recent Development

11.24 Ardena

11.24.1 Ardena Company Details

11.24.2 Ardena Business Overview

11.24.3 Ardena Chemical Drug CDMO Introduction

11.24.4 Ardena Revenue in Chemical Drug CDMO Business (2019-2024)

11.24.5 Ardena Recent Development

11.25 CPL

11.25.1 CPL Company Details

11.25.2 CPL Business Overview

11.25.3 CPL Chemical Drug CDMO Introduction

11.25.4 CPL Revenue in Chemical Drug CDMO Business (2019-2024)

11.25.5 CPL Recent Development

11.26 UPM Pharmaceuticals

11.26.1 UPM Pharmaceuticals Company Details

11.26.2 UPM Pharmaceuticals Business Overview

11.26.3 UPM Pharmaceuticals Chemical Drug CDMO Introduction

11.26.4 UPM Pharmaceuticals Revenue in Chemical Drug CDMO Business (2019-2024)

11.26.5 UPM Pharmaceuticals Recent Development

11.27 FUJIFILM Diosynth Biotechnologies

11.27.1 FUJIFILM Diosynth Biotechnologies Company Details

11.27.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.27.3 FUJIFILM Diosynth Biotechnologies Chemical Drug CDMO Introduction

11.27.4 FUJIFILM Diosynth Biotechnologies Revenue in Chemical Drug CDMO Business (2019-2024)

11.27.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.28 Groupe Parima

11.28.1 Groupe Parima Company Details

11.28.2 Groupe Parima Business Overview

11.28.3 Groupe Parima Chemical Drug CDMO Introduction

11.28.4 Groupe Parima Revenue in Chemical Drug CDMO Business (2019-2024)

11.28.5 Groupe Parima Recent Development

11.29 TBD Pharmatech

11.29.1 TBD Pharmatech Company Details

11.29.2 TBD Pharmatech Business Overview

11.29.3 TBD Pharmatech Chemical Drug CDMO Introduction

11.29.4 TBD Pharmatech Revenue in Chemical Drug CDMO Business (2019-2024)

11.29.5 TBD Pharmatech Recent Development

11.30 Avid Bioservices

11.30.1 Avid Bioservices Company Details

11.30.2 Avid Bioservices Business Overview

11.30.3 Avid Bioservices Chemical Drug CDMO Introduction

11.30.4 Avid Bioservices Revenue in Chemical Drug CDMO Business (2019-2024)

11.30.5 Avid Bioservices Recent Development

11.31 NextPharma

11.31.1 NextPharma Company Details

11.31.2 NextPharma Business Overview

11.31.3 NextPharma Chemical Drug CDMO Introduction

11.31.4 NextPharma Revenue in Chemical Drug CDMO Business (2019-2024)

11.31.5 NextPharma Recent Development

11.32 Alcami

11.32.1 Alcami Company Details

11.32.2 Alcami Business Overview

11.32.3 Alcami Chemical Drug CDMO Introduction

11.32.4 Alcami Revenue in Chemical Drug CDMO Business (2019-2024)

11.32.5 Alcami Recent Development

11.33 Societal CDMO

11.33.1 Societal CDMO Company Details

11.33.2 Societal CDMO Business Overview

11.33.3 Societal CDMO Chemical Drug CDMO Introduction

11.33.4 Societal CDMO Revenue in Chemical Drug CDMO Business (2019-2024)

11.33.5 Societal CDMO Recent Development

11.34 MedPharm

11.34.1 MedPharm Company Details

11.34.2 MedPharm Business Overview

11.34.3 MedPharm Chemical Drug CDMO Introduction

11.34.4 MedPharm Revenue in Chemical Drug CDMO Business (2019-2024)

11.34.5 MedPharm Recent Development

11.35 Euroapi

11.35.1 Euroapi Company Details

11.35.2 Euroapi Business Overview

11.35.3 Euroapi Chemical Drug CDMO Introduction

11.35.4 Euroapi Revenue in Chemical Drug CDMO Business (2019-2024)

11.35.5 Euroapi Recent Development

11.36 BioVectra

11.36.1 BioVectra Company Details

11.36.2 BioVectra Business Overview

11.36.3 BioVectra Chemical Drug CDMO Introduction

11.36.4 BioVectra Revenue in Chemical Drug CDMO Business (2019-2024)

11.36.5 BioVectra Recent Development

11.37 Pfizer CentreOne

11.37.1 Pfizer CentreOne Company Details

11.37.2 Pfizer CentreOne Business Overview

11.37.3 Pfizer CentreOne Chemical Drug CDMO Introduction

11.37.4 Pfizer CentreOne Revenue in Chemical Drug CDMO Business (2019-2024)

11.37.5 Pfizer CentreOne Recent Development

11.38 Fermion

11.38.1 Fermion Company Details

11.38.2 Fermion Business Overview

11.38.3 Fermion Chemical Drug CDMO Introduction

11.38.4 Fermion Revenue in Chemical Drug CDMO Business (2019-2024)

11.38.5 Fermion Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

Catalent

Thermo Fisher Scientific

Lonza

Siegfried

Recipharm

Boehringer Ingelheim

WuXi AppTech

Wuxi Biologics

Fareva

Samsung Biologics

Aenova

Delpharm

Strides Pharma

Piramal

Famar

Curia

Jubilant

Vetter

AGC Pharma Chemicals

Asymchem

Pharmaron

Eurofins

Ascendia Pharmaceuticals

Ardena

CPL

UPM Pharmaceuticals

FUJIFILM Diosynth Biotechnologies

Groupe Parima

TBD Pharmatech

Avid Bioservices

NextPharma

Alcami

Societal CDMO

MedPharm Ltd.

EUROAPI

BioVectra

Pfizer CentreOne

Fermion

List of Tables

Table 1. Global Chemical Drug CDMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of API CDMO

Table 3. Key Players of FDF CDMO

Table 4. Key Players of Packaging CDMO

Table 5. Key Players of Other

Table 6. Global Chemical Drug CDMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Chemical Drug CDMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Chemical Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Chemical Drug CDMO Market Share by Region (2019-2024)

Table 10. Global Chemical Drug CDMO Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Chemical Drug CDMO Market Share by Region (2025-2030)

Table 12. Chemical Drug CDMO Market Trends

Table 13. Chemical Drug CDMO Market Drivers

Table 14. Chemical Drug CDMO Market Challenges

Table 15. Chemical Drug CDMO Market Restraints

Table 16. Global Chemical Drug CDMO Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Chemical Drug CDMO Market Share by Players (2019-2024)

Table 18. Global Top Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Drug CDMO as of 2023)

Table 19. Ranking of Global Top Chemical Drug CDMO Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Chemical Drug CDMO Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Chemical Drug CDMO, Headquarters and Area Served

Table 22. Global Key Players of Chemical Drug CDMO, Product and Application

Table 23. Global Key Players of Chemical Drug CDMO, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Chemical Drug CDMO Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Chemical Drug CDMO Revenue Market Share by Type (2019-2024)

Table 27. Global Chemical Drug CDMO Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Chemical Drug CDMO Revenue Market Share by Type (2025-2030)

Table 29. Global Chemical Drug CDMO Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Chemical Drug CDMO Revenue Market Share by Application (2019-2024)

Table 31. Global Chemical Drug CDMO Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Chemical Drug CDMO Revenue Market Share by Application (2025-2030)

Table 33. North America Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Chemical Drug CDMO Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Chemical Drug CDMO Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chemical Drug CDMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Chemical Drug CDMO Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Chemical Drug CDMO Market Size by Country (2025-2030) & (US$ Million)

Table 48. Catalent Company Details

Table 49. Catalent Business Overview

Table 50. Catalent Chemical Drug CDMO Product

Table 51. Catalent Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 52. Catalent Recent Development

Table 53. Thermo Fisher Scientific Company Details

Table 54. Thermo Fisher Scientific Business Overview

Table 55. Thermo Fisher Scientific Chemical Drug CDMO Product

Table 56. Thermo Fisher Scientific Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 57. Thermo Fisher Scientific Recent Development

Table 58. Lonza Company Details

Table 59. Lonza Business Overview

Table 60. Lonza Chemical Drug CDMO Product

Table 61. Lonza Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 62. Lonza Recent Development

Table 63. Siegfried Company Details

Table 64. Siegfried Business Overview

Table 65. Siegfried Chemical Drug CDMO Product

Table 66. Siegfried Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 67. Siegfried Recent Development

Table 68. Recipharm Company Details

Table 69. Recipharm Business Overview

Table 70. Recipharm Chemical Drug CDMO Product

Table 71. Recipharm Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 72. Recipharm Recent Development

Table 73. Boehringer Ingelheim Company Details

Table 74. Boehringer Ingelheim Business Overview

Table 75. Boehringer Ingelheim Chemical Drug CDMO Product

Table 76. Boehringer Ingelheim Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 77. Boehringer Ingelheim Recent Development

Table 78. WuXi AppTech Company Details

Table 79. WuXi AppTech Business Overview

Table 80. WuXi AppTech Chemical Drug CDMO Product

Table 81. WuXi AppTech Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 82. WuXi AppTech Recent Development

Table 83. WuXi Biologics Company Details

Table 84. WuXi Biologics Business Overview

Table 85. WuXi Biologics Chemical Drug CDMO Product

Table 86. WuXi Biologics Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 87. WuXi Biologics Recent Development

Table 88. Fareva Company Details

Table 89. Fareva Business Overview

Table 90. Fareva Chemical Drug CDMO Product

Table 91. Fareva Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 92. Fareva Recent Development

Table 93. Samsung Biologics Company Details

Table 94. Samsung Biologics Business Overview

Table 95. Samsung Biologics Chemical Drug CDMO Product

Table 96. Samsung Biologics Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 97. Samsung Biologics Recent Development

Table 98. Aenova Company Details

Table 99. Aenova Business Overview

Table 100. Aenova Chemical Drug CDMO Product

Table 101. Aenova Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 102. Aenova Recent Development

Table 103. Delpharm Company Details

Table 104. Delpharm Business Overview

Table 105. Delpharm Chemical Drug CDMO Product

Table 106. Delpharm Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 107. Delpharm Recent Development

Table 108. Strides Pharma Company Details

Table 109. Strides Pharma Business Overview

Table 110. Strides Pharma Chemical Drug CDMO Product

Table 111. Strides Pharma Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 112. Strides Pharma Recent Development

Table 113. Piramal Company Details

Table 114. Piramal Business Overview

Table 115. Piramal Chemical Drug CDMO Product

Table 116. Piramal Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 117. Piramal Recent Development

Table 118. Famar Company Details

Table 119. Famar Business Overview

Table 120. Famar Chemical Drug CDMO Product

Table 121. Famar Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 122. Famar Recent Development

Table 123. Curia Company Details

Table 124. Curia Business Overview

Table 125. Curia Chemical Drug CDMO Product

Table 126. Curia Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 127. Curia Recent Development

Table 128. Jubilant Company Details

Table 129. Jubilant Business Overview

Table 130. Jubilant Chemical Drug CDMO Product

Table 131. Jubilant Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 132. Jubilant Recent Development

Table 133. Vetter Company Details

Table 134. Vetter Business Overview

Table 135. Vetter Chemical Drug CDMO Product

Table 136. Vetter Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 137. Vetter Recent Development

Table 138. AGC Pharma Chemicals Company Details

Table 139. AGC Pharma Chemicals Business Overview

Table 140. AGC Pharma Chemicals Chemical Drug CDMO Product

Table 141. AGC Pharma Chemicals Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 142. AGC Pharma Chemicals Recent Development

Table 143. Asymchem Company Details

Table 144. Asymchem Business Overview

Table 145. Asymchem Chemical Drug CDMO Product

Table 146. Asymchem Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 147. Asymchem Recent Development

Table 148. Pharmaron Company Details

Table 149. Pharmaron Business Overview

Table 150. Pharmaron Chemical Drug CDMO Product

Table 151. Pharmaron Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 152. Pharmaron Recent Development

Table 153. Eurofins Company Details

Table 154. Eurofins Business Overview

Table 155. Eurofins Chemical Drug CDMO Product

Table 156. Eurofins Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 157. Eurofins Recent Development

Table 158. Ascendia Pharmaceuticals Company Details

Table 159. Ascendia Pharmaceuticals Business Overview

Table 160. Ascendia Pharmaceuticals Chemical Drug CDMO Product

Table 161. Ascendia Pharmaceuticals Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 162. Ascendia Pharmaceuticals Recent Development

Table 163. Ardena Company Details

Table 164. Ardena Business Overview

Table 165. Ardena Chemical Drug CDMO Product

Table 166. Ardena Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 167. Ardena Recent Development

Table 168. CPL Company Details

Table 169. CPL Business Overview

Table 170. CPL Chemical Drug CDMO Product

Table 171. CPL Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 172. CPL Recent Development

Table 173. UPM Pharmaceuticals Company Details

Table 174. UPM Pharmaceuticals Business Overview

Table 175. UPM Pharmaceuticals Chemical Drug CDMO Product

Table 176. UPM Pharmaceuticals Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 177. UPM Pharmaceuticals Recent Development

Table 178. FUJIFILM Diosynth Biotechnologies Company Details

Table 179. FUJIFILM Diosynth Biotechnologies Business Overview

Table 180. FUJIFILM Diosynth Biotechnologies Chemical Drug CDMO Product

Table 181. FUJIFILM Diosynth Biotechnologies Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 182. FUJIFILM Diosynth Biotechnologies Recent Development

Table 183. Groupe Parima Company Details

Table 184. Groupe Parima Business Overview

Table 185. Groupe Parima Chemical Drug CDMO Product

Table 186. Groupe Parima Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 187. Groupe Parima Recent Development

Table 188. TBD Pharmatech Company Details

Table 189. TBD Pharmatech Business Overview

Table 190. TBD Pharmatech Chemical Drug CDMO Product

Table 191. TBD Pharmatech Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 192. TBD Pharmatech Recent Development

Table 193. Avid Bioservices Company Details

Table 194. Avid Bioservices Business Overview

Table 195. Avid Bioservices Chemical Drug CDMO Product

Table 196. Avid Bioservices Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 197. Avid Bioservices Recent Development

Table 198. NextPharma Company Details

Table 199. NextPharma Business Overview

Table 200. NextPharma Chemical Drug CDMO Product

Table 201. NextPharma Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 202. NextPharma Recent Development

Table 203. Alcami Company Details

Table 204. Alcami Business Overview

Table 205. Alcami Chemical Drug CDMO Product

Table 206. Alcami Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 207. Alcami Recent Development

Table 208. Societal CDMO Company Details

Table 209. Societal CDMO Business Overview

Table 210. Societal CDMO Chemical Drug CDMO Product

Table 211. Societal CDMO Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 212. Societal CDMO Recent Development

Table 213. MedPharm Company Details

Table 214. MedPharm Business Overview

Table 215. MedPharm Chemical Drug CDMO Product

Table 216. MedPharm Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 217. MedPharm Recent Development

Table 218. Euroapi Company Details

Table 219. Euroapi Business Overview

Table 220. Euroapi Chemical Drug CDMO Product

Table 221. Euroapi Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 222. Euroapi Recent Development

Table 223. BioVectra Company Details

Table 224. BioVectra Business Overview

Table 225. BioVectra Chemical Drug CDMO Product

Table 226. BioVectra Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 227. BioVectra Recent Development

Table 228. Pfizer CentreOne Company Details

Table 229. Pfizer CentreOne Business Overview

Table 230. Pfizer CentreOne Chemical Drug CDMO Product

Table 231. Pfizer CentreOne Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 232. Pfizer CentreOne Recent Development

Table 233. Fermion Company Details

Table 234. Fermion Business Overview

Table 235. Fermion Chemical Drug CDMO Product

Table 236. Fermion Revenue in Chemical Drug CDMO Business (2019-2024) & (US$ Million)

Table 237. Fermion Recent Development

Table 238. Research Programs/Design for This Report

Table 239. Key Data Information from Secondary Sources

Table 240. Key Data Information from Primary Sources

Table 241. Authors List of This Report

List of Figures

Figure 1. Chemical Drug CDMO Picture

Figure 2. Global Chemical Drug CDMO Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Chemical Drug CDMO Market Share by Type: 2023 VS 2030

Figure 4. API CDMO Features

Figure 5. FDF CDMO Features

Figure 6. Packaging CDMO Features

Figure 7. Other Features

Figure 8. Global Chemical Drug CDMO Market Size by Application (2024-2030) & (US$ Million)

Figure 9. Global Chemical Drug CDMO Market Share by Application: 2023 VS 2030

Figure 10. Large Enterprise Case Studies

Figure 11. Small and Medium Enterprises Case Studies

Figure 12. Other Case Studies

Figure 13. Chemical Drug CDMO Report Years Considered

Figure 14. Global Chemical Drug CDMO Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Chemical Drug CDMO Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Chemical Drug CDMO Market Share by Region: 2023 VS 2030

Figure 17. Global Chemical Drug CDMO Market Share by Players in 2023

Figure 18. Global Top Chemical Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemical Drug CDMO as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Chemical Drug CDMO Revenue in 2023

Figure 20. North America Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 22. United States Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 26. Germany Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Chemical Drug CDMO Market Share by Region (2019-2030)

Figure 34. China Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 42. Mexico Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Chemical Drug CDMO Market Share by Country (2019-2030)

Figure 46. Turkey Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. UAE Chemical Drug CDMO Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Catalent Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 51. Lonza Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 52. Siegfried Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 53. Recipharm Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 54. Boehringer Ingelheim Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 55. WuXi AppTech Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 56. WuXi Biologics Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 57. Fareva Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 58. Samsung Biologics Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 59. Aenova Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 60. Delpharm Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 61. Strides Pharma Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 62. Piramal Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 63. Famar Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 64. Curia Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 65. Jubilant Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 66. Vetter Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 67. AGC Pharma Chemicals Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 68. Asymchem Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 69. Pharmaron Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 70. Eurofins Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 71. Ascendia Pharmaceuticals Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 72. Ardena Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 73. CPL Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 74. UPM Pharmaceuticals Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 75. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 76. Groupe Parima Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 77. TBD Pharmatech Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 78. Avid Bioservices Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 79. NextPharma Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 80. Alcami Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 81. Societal CDMO Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 82. MedPharm Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 83. Euroapi Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 84. BioVectra Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 85. Pfizer CentreOne Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 86. Fermion Revenue Growth Rate in Chemical Drug CDMO Business (2019-2024)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chemical CDMO Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Specialty Chemicals CDMO Service Market Research Report 2024

Global Small Molecule Drug CDMO Services Market Research Report 2024

Global Formulation CDMO Services Market Research Report 2024

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Global Chemical Drug CMO Market Research Report 2024

Global Full Service CDMO Market Research Report 2024

Pharmaceutical CDMO Pharmaceutical Contract Development and Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Small Molecules CDMO Services Market Research Report 2024

Pharmaceutical CDMO Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Large Molecule Drug Substance CDMO Market Research Report 2024

Global Antibody Drug CDMO Service Market Research Report 2024

Global Chemical Drug CXO Services Market Research Report 2024

Global Topical Drugs CDMO Market Research Report 2025

Pharmaceutical CDMO Services Market

Global Contract Dose Manufacturing Market Insights Forecast to 2030

Global Biopharmaceutical CDMO Service Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions